George Βertsias

DNA damage in macrophages drives immune autoreactivity via nuclear antigen presentation

EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update

Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study

Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey

Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study

Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression

Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events

Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways

A path to Glucocorticoid Stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus

Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective study

Integrating carotid Doppler, greyscale US, and aortic oscillometry to evaluate macroangiopathy in myositides: the MYOCARD cohort

P70 Exposure to DORIS ≥50% of time and to LLDAS ≥60% of observation time exhibit the best combination of feasibility and protection against adverse outcomes in moderate-to-severe SLE

P38 Role of conventional magnetic resonance imaging in the evaluation of patients with neuropsychiatric involvement in systemic lupus erythematosus (SLE)

POS1118 ROLE OF CONVENTIONAL MAGNETIC RESONANCE IMAGING IN THE EVALUATION OF PATIENTS WITH NEUROPSYCHIATRIC INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

EULAR study group on ‘MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders

2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Arthritides and Connective Tissue Diseases: A Literature Review

Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Vasculitides: A Literature Review

ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products

Organ damage is a major determinant of work productivity impairment in Behçet’s syndrome: a post hoc analysis of the BODI validation study

Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs

Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis

IL-6 Signaling Attenuates TNF-α Production by Plasmacytoid Dendritic Cells in Rheumatoid Arthritis

Accrual of organ damage in Behçet’s syndrome: trajectory, associated factors, and impact on patients’ quality of life over a 2-year prospective follow-up study

AB0630 Assessment of organ damage accrual in Behçet's Syndrome over 2-year follow-up: results from the BODI Project longitudinal extension.